Literature DB >> 21539489

The use of ketamine in complex regional pain syndrome: possible mechanisms.

Robert J Schwartzman1, Guillermo M Alexander, John R Grothusen.   

Abstract

Complex regional pain syndrome is a neuropathic pain syndrome that is characterized by: severe pain beyond the area of injury; autonomic dysregulation; neurogenic edema; movement disorder; and atrophy and dystrophy. Ketamine is an open-channel NMDA blocker that only acts on those receptors whose Mg(2+) block has been lifted. It is effective in the treatment of the syndrome when standard treatments have failed. Different protocols are utilized depending on the severity of illness. There have been no serious ketamine-induced complications from these protocols, owing to careful psychological screening and the liberal use of midazolam and lorazepam to counter any psychomimetic effects and clonidine to block possible 'Olney's' lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21539489     DOI: 10.1586/ern.11.31

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  12 in total

1.  Gabapentin and (S)-pregabalin decrease intracellular D-serine concentrations in PC-12 cells.

Authors:  Nagendra S Singh; Rajib K Paul; Marc C Torjman; Irving W Wainer
Journal:  Neurosci Lett       Date:  2012-12-27       Impact factor: 3.046

2.  Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.

Authors:  Xiaochen Zhao; Swarajya Lakshmi Vattem Venkata; Ruin Moaddel; Dave A Luckenbaugh; Nancy E Brutsche; Lobna Ibrahim; Carlos A Zarate; Donald E Mager; Irving W Wainer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 3.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

4.  Anesthetic Management of a Complex Regional Pain Syndrome (CRPS) Patient With Ketamine.

Authors:  Tarun Mundluru; Mana Saraghi
Journal:  Anesth Prog       Date:  2020-12-01

5.  Successful Treatment of Long Standing Complex Regional Pain Syndrome with Hyperbaric Oxygen Therapy.

Authors:  Karen Binkley; Rita Katznelson
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-14       Impact factor: 4.147

Review 6.  Ketamine: Current applications in anesthesia, pain, and critical care.

Authors:  Madhuri S Kurdi; Kaushic A Theerth; Radhika S Deva
Journal:  Anesth Essays Res       Date:  2014 Sep-Dec

Review 7.  Complex regional pain syndrome: a recent update.

Authors:  En Lin Goh; Swathikan Chidambaram; Daqing Ma
Journal:  Burns Trauma       Date:  2017-01-19

8.  Hsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome.

Authors:  Richa Pande; Ayush Parikh; Botros Shenoda; Sujay Ramanathan; Guillermo M Alexander; Robert J Schwartzman; Seena K Ajit
Journal:  Biomed Pharmacother       Date:  2021-05-29       Impact factor: 7.419

9.  Effect of intravenous low-dose S-ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study.

Authors:  Thomas J P Mangnus; Maaike Dirckx; Krishna D Bharwani; Cecile C de Vos; Sander P G Frankema; Dirk L Stronks; Frank J P M Huygen
Journal:  Pain Pract       Date:  2021-07-24       Impact factor: 3.079

10.  Hsa-miR-34a mediated repression of corticotrophin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome.

Authors:  Botros B Shenoda; Guillermo M Alexander; Seena K Ajit
Journal:  J Transl Med       Date:  2016-03-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.